2010 Fiscal Year Final Research Report
Development of cancer vaccine therapy using dendritic cells transduced with TGF-βsiRNA for digestive cancer
Project/Area Number |
20591533
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
General surgery
|
Research Institution | Wakayama Medical University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
YAMAUE Hiroki 和歌山県立医科大学, 医学部, 教授 (20191190)
IWAHASHI Makoto 和歌山県立医科大学, 医学部, 講師 (70244738)
NAKAMORI Mikihito 和歌山県立医科大学, 医学部, 講師 (10322372)
MATSUDA Kenji 和歌山県立医科大学, 医学部, 助教 (30398458)
NAKA Teiji 和歌山県立医科大学, 医学部, 学内助教 (00453184)
|
Project Period (FY) |
2008 – 2010
|
Keywords | 樹状細胞 / TGF-β / adenovirus vector / siRNA / 免疫遺伝子治療 |
Research Abstract |
Recently, several studies have shown that TGF-βproduced from tumor cells would inhibit cytotoxic activity of cytotoxic T lymphocytes(CTLs) and increase the number of regulatory T cells(Treg) in tumor local environment. Therefore, as administration of TGF-βsiRNA would inhibit production of TGF-βin tumor environment, it would be expect that antitumor effect of immunotherapy using dendritic cells(DCs) could be enhanced. This study was examined whether antigen-specific CTL responses and therapeutic immunity could be enhanced by genetically-modified DCs expressing CEA antigen and TGF-βsiRNA. Consequently, an effective antitumor immune response was not induced because of unstable expression of TGF-βsiRNA. Further investigation is needed to optimize this vaccine therapy to achieve the obvious benefit in clinical application.
|
Research Products
(30 results)
-
-
-
-
[Journal Article] Dendritic cells adenovirally-transduced with full-length mesothelin cDNA elicit mesothelin-specific cytotoxicity against pancreatic cancer cell lines in vitro2011
Author(s)
Miyazawa M, Iwahashi M, Ojima T, Katsuda M, Nakamura M, Nakamori M, Ueda K, Naka T, Hayata K, Iida T, Yamaue H
-
Journal Title
Cancer Lett
Volume: 305(1)
Pages: 32-9
Peer Reviewed
-
[Journal Article] Tumor-infiltrating CD4+Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer2011
Author(s)
Iida T, Iwahashi M, Katsuda M, Ishida K, Nakamori M, Nakamura M, Naka T, Ojima T, Ueda K, Hayata K, Nakamura Y, Yamaue H
-
Journal Title
Oncol Rep
Volume: 25(5)
Pages: 1271-7
Peer Reviewed
-
-
[Journal Article] Clinicopathological characteristics of remnant gastric cancer after a distal gastrectomy2010
Author(s)
Ojima T, Iwahashi M, Nakamori M, Nakamura M, Naka T, Katsuda M, Iida T, Tsuji T, Hayata K, Takifuji K, Yamaue H
-
Journal Title
J Gastrointest Surg
Volume: 14(2)
Pages: 277-81
Peer Reviewed
-
[Journal Article] Bacillus Calmette-Guerin cell-wall skeleton enhances the killing activity of cytotoxic lymphocyte-activated human dendritic cells transduced with the prostate-specific antigen gene2009
Author(s)
Fujii R, Iwahashi M, Kikkawa K, Inagaki T, Kohjimoto Y, Ojima T, Mori T, Kuramoto T, Nishizawa S, Azuma I, Yamaue H, Shinka T, Hara I
-
Journal Title
BJU Int
Volume: 104(11)
Pages: 1766-73
Peer Reviewed
-
[Journal Article] Optimal dose of preoperative enteral immunonutrition for patients with esophageal cancer2009
Author(s)
Nakamura M, Iwahashi M, Takifuji K, Nakamori M, Naka T, Ishida K, Ojima T, Iida T, Katsuda M, Hayata K, Yamaue H
-
Journal Title
Surg Today
Volume: 39(10)
Pages: 855-60
Peer Reviewed
-
-
-
-
[Journal Article] Influence of overweight on patients with gastric cancer after undergoing curative gastrectomy : an analysis of 689 consecutive cases managed by a single center2009
Author(s)
Ojima T, Iwahashi M, Nakamori M, Nakamura M, Naka T, Ishida K, Ueda K, Katsuda M, Iida T, Tsuji T, Yamaue H
-
Journal Title
Arch Surg
Volume: 144(4)
Pages: 351-8
Peer Reviewed
-
-
[Presentation] 胃癌腫瘍微小環境におけるTregおよびTh17の動態解析2010
Author(s)
飯田武, 岩橋誠, 勝田将裕, 中森幹人, 中村公紀, 石田興一郎, 中禎二, 尾島敏康, 早田啓治, 辻俊明, 山上裕機
Organizer
第110回日本外科学会
Place of Presentation
名古屋
Year and Date
2010-04-09
-
-
-
-
[Presentation] 胃癌腫瘍微小環境におけるTh17およびTregの動態からみた癌免疫逃避機構の解析2009
Author(s)
飯田武, 岩橋誠, 勝田将裕, 中森幹人, 中村公紀, 石田興一郎, 中禎二, 尾島敏康, 早田啓治, 辻俊明, 山上裕機
Organizer
第22回日本バイオセラピー学会
Place of Presentation
大阪
Year and Date
2009-11-26
-
[Presentation] CpG-ODNによる癌抗原特異的エフェクター細胞の効率的誘導と抗腫瘍活性増強効果2009
Author(s)
勝田将裕, 岩橋誠, 中森幹人, 中村公紀, 松田健司, 中禎二, 尾島敏康, 飯田武, 宮澤基樹, 角田卓也, 中村祐輔, 山上裕機
Organizer
第22回日本バイオセラピー学会
Place of Presentation
大阪
Year and Date
2009-11-26
-
[Presentation] 進行食道癌に対するCpG-B併用新規腫瘍抗原ペプチドワクチン療法:第I相臨床試験の結果からみた将来展望2009
Author(s)
岩橋誠, 勝田将裕, 中森幹人, 中村公紀, 飯田武, 中禎二, 尾島敏康, 松田健司, 角田卓也, 中村祐輔, 山上裕機
Organizer
第22回日本バイオセラピー学会
Place of Presentation
大阪
Year and Date
2009-11-26
-
-
-
-
[Presentation] Phase I trial of vaccination of tumor specific peptides combined with CpG-B for patients with esophageal cancer2009
Author(s)
岩橋誠, 勝田将裕, 中森幹人, 中村公紀, 宮澤基樹, 松田健司, 中禎二, 尾島敏康, 飯田武, 角田卓也, 中村祐輔, 山上裕機
Organizer
第68回日本癌学会
Place of Presentation
横浜
Year and Date
2009-10-01
-
-
-
-
-
[Presentation] CEA遺伝子Th 1-type cytokine遺伝子導入樹状細胞を用いた癌ワクチン療法-CEA transgenic miceを用いた検討-2008
Author(s)
尾島敏康, 岩橋誠, 中村公紀, 中森幹人, 中禎二, 上田健太郎, 石田興一郎, 勝田将裕, 飯田武, 宮澤基樹, 山上裕機
Organizer
第46回日本癌治療学会
Place of Presentation
名古屋
Year and Date
2008-10-30